Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Consumer Products

WuXi, BioLingus team up for sublingual delivery technology

by Rick Mullin
February 22, 2019 | A version of this story appeared in Volume 97, Issue 8

 

A photo of an Indian lotus flower.
Credit: Shutterstock
The seeds of the Indian lotus plant can preserve protein function for up to 1,000 years, BioLingus says.

STA Pharmaceutical and BioLingus will collaborate on development and marketing of sublingual drug delivery techniques. STA, the contract development and manufacturing division of China’s WuXi AppTec, will have exclusive access to BioLingus’s technology for under-the-tongue delivery of drugs—including small molecules, peptides, and proteins—currently administered via injection. BioLingus says its technology is inspired by how plants keep proteins stable in their seeds over long periods of time.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.